Venture Certified
| 혁신성장유형 | 2024-03-20 ~ 2027-03-19 | 20240320030014 | 2024-03-20 |
Revenue CAGR +510.9%
| Item | 2024 | 2023 |
|---|---|---|
| Revenue | 0.6B | 0.1B |
| Operating Profit | -2.1B | -1.7B |
| Net Profit | -2.1B | -1.7B |
| Total Assets | 5.1B | 1.3B |
| Total Liabilities | 4.4B | 2.0B |
| Total Equity | 0.6B | -0.7B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Debt Ratio 695.7%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -2B
2 Consecutive Years of Net Loss
▲ 510.9%
▼ 23.1%
▲ 79.9%
▲ 346.0%
▼ 241.1%
| Name | Position | Role |
|---|---|---|
| 임성혁 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 광주시",
"ceo_name": "임성혁",
"certificate": [
{
"cert_number": "20240320030014",
"changes": "",
"disclosure_date": "2024-03-20",
"first_cert_date": "2024-03-20",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2024-03-20 ~ 2027-03-19"
}
],
"company_name": "헤리팜스 주식회사",
"corp_no": "134211-*******",
"financials": {
"2023": {
"capital_stock": 100000000,
"cost_of_sales": 57593000,
"current_assets": 91381000,
"current_liabilities": 14777000,
"gross_profit": -47533000,
"net_income": -172418000,
"net_income_bs": -172418000,
"non_current_assets": 40978000,
"non_current_liabilities": 190000000,
"non_operating_expenses": 103000,
"non_operating_income": 3000,
"operating_profit": -172318000,
"revenue": 10060000,
"sga_expenses": 124785000,
"total_assets": 132359000,
"total_equity": -72418000,
"total_liabilities": 204777000
},
"2024": {
"capital_stock": 450000000,
"cost_of_sales": 38064000,
"current_assets": 338628000,
"current_liabilities": 212859000,
"gross_profit": 23395000,
"net_income": -213922000,
"net_income_bs": -213922000,
"non_current_assets": 167891000,
"non_current_liabilities": 230000000,
"non_operating_expenses": 3658000,
"non_operating_income": 1858000,
"operating_profit": -212122000,
"revenue": 61459000,
"sga_expenses": 235517000,
"total_assets": 506519000,
"total_equity": 63660000,
"total_liabilities": 442859000
}
},
"industry": "농림수산학 및 수의학 연구개발업",
"investment": [],
"main_products": "생물학적제제 제조업, 종자생산업, 미생물종균, 배양체 생물학적 소재개발, 생물학 연구객발",
"phone": "063-762-****",
"years": [
2024,
2023
]
}Data Quality: 7/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |